Continuous Improvement Through Differential Trajectories of Individual Minimal Disease Activity Criteria with Guselkumab in Active Psoriatic Arthritis: Post hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
COATES LC., Rahman P., Mease PJ., Shawi M., Rampakakis E., Kollmeier AP., Xu XL., Chakravarty SD., McInnes IB., Tam L-S.